Ушбу иш иқтибос қилган ишлар

167 та иш

Иш: The microbial metabolome: remodeling the therapeutic landscape in hematologic malignancies

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
Thawinee Jantararoungtong, Supaporn Wiwattanakul, Rawiporn Tiyasirichokchai +10
Мақола20212 иқтибос
ABI
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
Marcin Jasiński, Jarosław Biliński, Grzegorz Basak
Шарҳ мақола20212 иқтибос
ABI
Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease
Quentin Le Bastard, Patrice Chevallier, Emmanuel Montassier
Шарҳ мақола20212 иқтибос
ABI
Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response
Huanhuan Yan, Rui Su, Hongwei Xue +3
Шарҳ мақола20212 иқтибос
ABI
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
Paul Feuerstadt, Thomas J. Louie, Bret Lashner +20
Мақола20222 иқтибос
ABI
Short chain fatty acids: Microbial metabolites for gut-brain axis signalling
Kenneth J. O’Riordan, Michael Collins, Gerard M. Moloney +7
Шарҳ мақола20222 иқтибос
ABI
The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow
Dachuan Zhang, Xin Gao, Huihui Li +6
Мақола20222 иқтибос
ABI
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas +40
Мақола20222 иқтибос
ABI
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Melody Smith, Anqi Dai, Guido Ghilardi +46
Мақола20222 иқтибос
ABI
Humanized Germ-Free Mice for Investigating the Intervention Effect of Commensal Microbiome on Cancer Immunotherapy
Xinning Wang, Chengwei Wu, Hong Wei
Шарҳ мақола20222 иқтибос
ABI
Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease
Slavica Lazarević, Maja Đanić, Hani Al‐Salami +2
Шарҳ мақола20222 иқтибос
ABI
An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species
Sigal Leviatan, Saar Shoer, Daphna Rothschild +2
Мақола20222 иқтибос
ABI
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets
Urvi A. Shah, Kylee Maclachlan, Andriy Derkach +35
Мақола20222 иқтибос
ABI
Hematopoietic stem and progenitor cells integrate microbial signals to promote post‐inflammation gut tissue repair
Maiko Sezaki, Yoshikazu Hayashi, Gaku Nakato +12
Мақола20222 иқтибос
ABI
In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111®
Shahneela Mazhar, Ekaterina V. Khokhlova, Joan Colom +3
Мақола20232 иқтибос
ABI
Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy
Dávid Dóra, Syeda Mahak Zahra Bokhari, Kenan Aloss +5
Шарҳ мақола20232 иқтибос
ABI
Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation
Ehsan Yazdandoust, Abbas Hajifathali, Elham Roshandel +5
Мақола20232 иқтибос
ABI
Intestinal Microbes and Hematological Malignancies
Yinghong Zhu, Qiaohui Yang, Qin Yang +2
Шарҳ мақола20232 иқтибос
ABI
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection
Thomas Louie, Yoav Golan, Sahil Khanna +12
Мақола20232 иқтибос
ABI
Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans
Nahathai Dukaew, Patcharawadee Thongkumkoon, Nutnicha Sirikaew +8
Мақола20232 иқтибос
ABI
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Alexandra L. Degraeve, Vincent Haufroid, Axelle Loriot +5
Мақола20232 иқтибос
ABI
Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
Riccardo Masetti, Davide Leardini, Edoardo Muratore +17
Мақола20232 иқтибос
ABI
Role of the gut microbiota in hematologic cancer
Patricia Guevara‐Ramírez, Santiago Cadena-Ullauri, Elius Paz‐Cruz +3
Шарҳ мақола20232 иқтибос
ABI
Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner
Ekaterina Kachur, Jai N. Patel, Allison Morse +2
Шарҳ мақола20232 иқтибос
ABI
Comparative analysis of shotgun metagenomics and 16S rDNA sequencing of gut microbiota in migratory seagulls
Feng Liao, Yilan Xia, Wenpeng Gu +2
Мақола20232 иқтибос
ABI

Ушбу иш иқтибос қилган ишлар

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia

The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias

Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft <i>vs</i> host disease

Pharmacomicrobiology of Methotrexate in Rheumatoid Arthritis: Gut Microbiome as Predictor of Therapeutic Response

SER-109, an Oral Microbiome Therapy for Recurrent <i>Clostridioides difficile</i> Infection

Short chain fatty acids: Microbial metabolites for gut-brain axis signalling

The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Humanized Germ-Free Mice for Investigating the Intervention Effect of Commensal Microbiome on Cancer Immunotherapy

Gut Microbiota Metabolism of Azathioprine: A New Hallmark for Personalized Drug-Targeted Therapy of Chronic Inflammatory Bowel Disease

An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species

Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets

Hematopoietic stem and progenitor cells integrate microbial signals to promote post‐inflammation gut tissue repair

In vitro and in silico assessment of probiotic and functional properties of Bacillus subtilis DE111®

Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy

Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation

Intestinal Microbes and Hematological Malignancies

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent <i>Clostridioides difficile</i> Infection

Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans

Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children

Role of the gut microbiota in hematologic cancer

Post-Transplant Cyclophosphamide for the Prevention of Graft-vs.-Host Disease in Allogeneic Hematopoietic Cell Transplantation: A Guide to Management for the Advanced Practitioner

Comparative analysis of shotgun metagenomics and 16S rDNA sequencing of gut microbiota in migratory seagulls